Drug intelligence / Profile preview

streptococcus salivarius (Universidade de Passo Fundo)

Development stage
Unknown
Lead developer
BLIS Technologies
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral, Buccal
01

Overview

Streptococcus salivarius is a gram-positive, facultative anaerobic bacterium that is a prominent member of the healthy human oral microbiota. It is developed as a live biotherapeutic product (probiotic) to manage oral conditions such as halitosis, dental caries, and pharyngitis. The bacterium works by colonizing oral surfaces and outcompeting pathogenic, odor-producing bacteria. Many strains of S. salivarius produce bacteriocin-like inhibitory substances (BLIS), which are natural antimicrobial peptides that specifically inhibit the growth of competitors like Streptococcus pyogenes and various anaerobic species that produce volatile sulfur compounds (VSCs). In clinical research, such as that conducted by the Universidade de Passo Fundo, it is often studied in conjunction with prebiotics like inulin to enhance its colonization and efficacy in reducing tongue coating and bad breath.

Other names
S. salivariusStreptococcus salivarius

Beyond the preview

Go deeper on streptococcus salivarius (Universidade de Passo Fundo).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on streptococcus salivarius (Universidade de Passo Fundo).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call